Orange Book product · Generic (ANDA)
BRIVARACETAM
BRIVARACETAM
At a glance
Jun 09, 2022
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 09, 2022
4 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
BRIVARACETAM
Strength
10MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 214748
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of BRIVARACETAM
- 2016BRIVIACTBrand (NDA)
NDA 205837 · UCB INC
- 2016BRIVIACTBrand (NDA)
NDA 205838 · UCB INC
- 2016BRIVIACTBrand (NDA)
NDA 205836 · UCB INC
- 2026BRIVARACETAMGeneric (ANDA)
ANDA 218249 · HAINAN POLY
- 2026BRIVARACETAMGeneric (ANDA)
ANDA 214880 · MICRO LABS
- 2026BRIVARACETAMGeneric (ANDA)
ANDA 214924 · MSN
- 2026BRIVARACETAMGeneric (ANDA)
ANDA 219772 · ALKEM LABS LTD
- 2026BRIVARACETAMGeneric (ANDA)
ANDA 220164 · LUPIN
- 2026BRIVARACETAMGeneric (ANDA)
ANDA 220385 · REGCON HOLDINGS
- 2026BRIVARACETAMGeneric (ANDA)
ANDA 218494 · ZHEJIANG POLY PHARM
- 2026BRIVARACETAMGeneric (ANDA)
ANDA 214875 · APOTEX
- 2026BRIVARACETAMGeneric (ANDA)
ANDA 220470 · CENTAUR PHARMS PVT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
